These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Levels of free and acetylized PAS in the blood after the administration ALPAS]. Kostić M; Krajovan R Tuberkuloza; 1966; 18(5):469-76. PubMed ID: 16296053 [No Abstract] [Full Text] [Related]
7. [Healing of destructive pulmonary tuberculosis depending on bacteriostatic effect of various methods of treatment]. Sokolova GB; Galenko NN; Kanevskaia SS Probl Tuberk; 1978 Nov; (11):30-5. PubMed ID: 103090 [No Abstract] [Full Text] [Related]
8. [Remote results of treatment of cutaneous tuberculosis by a combined method using streptomycin, isoniazid and P-aminosalicylic acid]. Arkuszewska C; Olszewska Z Przegl Dermatol; 1979; 66(5):561-6. PubMed ID: 523695 [No Abstract] [Full Text] [Related]
9. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state. Gad S; Tajber L; Corrigan OI; Healy AM J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439 [TBL] [Abstract][Full Text] [Related]
10. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)]. Baba H; Azuma Y Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance. Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the metabolism of para-aminosalicylic acid in the body. IV. Effect of sodium salt of para-animosalicylic acid administered orally in coated tablets soluble in the intestine on the bacteriostatic level and on drug tolerance]. Hornung S; Nilodemowicz E; Owsiński J; Rapf T Gruzlica; 1967 Jul; 35(7):657-64. PubMed ID: 4865322 [No Abstract] [Full Text] [Related]
13. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas]. Ursov IG; Volokitin FN; Borovinskaia TA Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002 [No Abstract] [Full Text] [Related]
14. [Remote results of the use of short-term artificial pneumothorax and intravenous intermittent chemotherapy in tuberculosis]. Ursov IG; Kuzina LN; Bolganova MN Sov Med; 1980; (3):3-5. PubMed ID: 6966426 [No Abstract] [Full Text] [Related]
15. PAS infusion in treatment of multidrug-resistant tuberculosis. Fodor T; Pataki G; Schrettner M Int J Tuberc Lung Dis; 2000 Feb; 4(2):187-8. PubMed ID: 10694102 [No Abstract] [Full Text] [Related]
16. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis. Mathur JB; Bahadur P; Agnihotri CB J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009 [No Abstract] [Full Text] [Related]
17. [Changes in various parameters of homeostasis in patients with pulmonary tuberculosis after intra-arterial administration of antibacterial preparations]. Goncharov VG; Kovalenko NN Probl Tuberk; 1985; (9):56-9. PubMed ID: 4070224 [No Abstract] [Full Text] [Related]